Login

16th Varenna Conference on Nuclear Reaction Mechanisms

11–16 Jun 2023
Villa Monastero
Europe/Zurich timezone

Session

Medical radioisotopes

16 Jun 2023, 09:00
Villa Monastero

Villa Monastero

Varenna (Italy)

Conveners

Medical radioisotopes

  • Luciano Canton

Presentation materials

There are no materials yet.

  1. 91. The development of radionuclides towards theragnostic application in nuclear medicine
    Nicholas P. van der Meulen (Laboratory of Radiochemistry, Paul Scherrer Institute, Villigen-PSI, Switzerland)
    16/06/2023, 09:00
    Medical radioisotopes

    The concept of “theragnostics” in nuclear medicine, ideally, involves the diagnosis and treatment of a
    patient using radioisotopes of the same element, to ensure what you image is what you treat. The
    concept is currently being followed by means of diagnosis with 68Ga, followed by radionuclide therapy
    using 177Lu.
    Researchers are pursuing the idea utilizing the same element, but different...

    Go to contribution page
  2. 89. CERN-MEDICIS: a unique facility for the production of non-conventional radionuclides for medical research
    Charlotte Duchemin (CERN EN/STI/RBS)
    16/06/2023, 09:30
    Medical radioisotopes

    The MEDICIS facility is a unique facility located at CERN dedicated to the production of non-conventional radionuclides for research and development in medical imaging, diagnostics and radiation therapy. Located in a laboratory equipped to safely handle unsealed radioactive samples, it comprises a dedicated isotope separator beam line, a target irradiation station at the 1.4 GeV Proton...

    Go to contribution page
  3. 68. Preliminary results of the theranostic 47Sc cyclotron proton-induced production with enriched 48Ti, 49Ti and 50Ti targets
    Liliana Mou (INFN-LNL)
    16/06/2023, 10:00
    Medical radioisotopes

    The scientific community interest in the production of the theranostic 47Sc, as underlined in the IAEA Coordinated Research Project (CRP) on 67Cu, 47Sc and 186Re [1], is due to its medically favourable decay characteristics (Eγ=159.381 keV Iγ=68.3%, Eβ-,mean=162.0 keV Iβ-=100%) suitable for therapeutic purposes and SPECT cameras for diagnosis. Moreover, 47Sc has a quite long half-life (T1/2 =...

    Go to contribution page
  4. 60. Optimized simulations of $^{50}$Ti(p,α) and $^{49}$Ti(d,α) reactions for hospital-cyclotron production of $^{47}$Sc
    Francesca Barbaro (INFN, Sezione di Padova, Padova, Italy; Dipartimento di Fisica dell’Università di Pavia, Pavia, Italy)
    16/06/2023, 10:20
    Medical radioisotopes

    Radionuclide $^{47}$Sc (T$_{1/2}$ = 3.35 d) represents a promising element for innovative radiopharmaceutical compounds suitable for theranostic applications, however an efficient and convenient production route has still to be identified. In this work we simulate the reactions $^{50}$Ti(p,α)$^{47}$Sc and $^{49}$Ti(d,α)$^{47}$Sc in view of a cyclotron production of $^{47}$Sc on enriched...

    Go to contribution page
  5. 22. $^{155}$Tb from natural targets: reaction modeling of $^{nat}$Tb(p,5n) and $^{nat}$Gd($\alpha$,x)
    Alessandro Colombi (University of Pavia and INFN - Pavia)
    16/06/2023, 10:40
    Medical radioisotopes

    Terbium has gained the attention of the community since it is the only element in the periodic table with four isotopes ($^{149}$Tb, $^{152}$Tb, $^{155}$Tb and $^{161}$Tb) that can be used for many clinical applications [1]. In particular, the isotope $^{155}$Tb, with the emission of Auger-electron and $\gamma$ rays, suitable respectively for therapy and for SPECT imaging, is a promising key...

    Go to contribution page
Building timetable...